Opaleye Management as of March 31, 2019
Portfolio Holdings for Opaleye Management
Opaleye Management holds 53 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Codexis (CDXS) | 8.4 | $30M | 1.5M | 20.53 | |
| Axogen (AXGN) | 6.4 | $23M | 1.1M | 21.06 | |
| Epizyme | 4.7 | $17M | 1.4M | 12.39 | |
| Cerecor | 3.7 | $13M | 2.3M | 5.84 | |
| Amarin Corporation (AMRN) | 3.7 | $13M | 645k | 20.76 | |
| Uniqure Nv (QURE) | 3.4 | $12M | 205k | 59.65 | |
| Ascendis Pharma A S (ASND) | 3.1 | $11M | 95k | 117.71 | |
| Tg Therapeutics (TGTX) | 3.0 | $11M | 1.4M | 8.04 | |
| Audentes Therapeutics | 3.0 | $11M | 280k | 39.02 | |
| Fibrogen (FGEN) | 3.0 | $11M | 200k | 54.35 | |
| Clementia | 2.9 | $10M | 400k | 26.10 | |
| Blueprint Medicines (BPMC) | 2.9 | $10M | 130k | 80.05 | |
| Invitae (NVTAQ) | 2.9 | $10M | 440k | 23.42 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.6 | $9.3M | 1.8M | 5.10 | |
| Imprimis Pharmaceuticals | 2.5 | $9.0M | 1.8M | 4.98 | |
| Magenta Therapeutics | 2.3 | $8.4M | 510k | 16.47 | |
| Ptc Therapeutics I (PTCT) | 2.2 | $8.0M | 214k | 37.64 | |
| Deciphera Pharmaceuticals (DCPH) | 2.2 | $7.9M | 340k | 23.21 | |
| Mirati Therapeutics | 2.1 | $7.7M | 105k | 73.30 | |
| Ocular Therapeutix (OCUL) | 2.1 | $7.5M | 1.9M | 3.97 | |
| Cymabay Therapeutics | 2.0 | $7.3M | 550k | 13.28 | |
| Odonate Therapeutics Ord | 2.0 | $7.2M | 325k | 22.11 | |
| Cytokinetics | 1.9 | $6.9M | 850k | 8.09 | |
| Tricida | 1.8 | $6.4M | 165k | 38.62 | |
| Eton Pharmaceuticals (ETON) | 1.7 | $6.1M | 765k | 8.00 | |
| Strongbridge Bioph shs usd | 1.6 | $5.7M | 1.2M | 4.98 | |
| Dermira | 1.5 | $5.4M | 400k | 13.55 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $5.4M | 200k | 26.85 | |
| Xoma Corp Del (XOMA) | 1.4 | $5.0M | 400k | 12.38 | |
| Horizon Pharma | 1.4 | $4.9M | 185k | 26.43 | |
| Viking Therapeutics (VKTX) | 1.3 | $4.8M | 485k | 9.94 | |
| Eidos Therapeutics | 1.3 | $4.7M | 200k | 23.45 | |
| Retrophin | 1.3 | $4.6M | 205k | 22.63 | |
| Abeona Therapeutics | 1.1 | $4.1M | 560k | 7.36 | |
| Cara Therapeutics (CARA) | 1.1 | $3.9M | 200k | 19.62 | |
| Avenue Therapeutics | 1.1 | $3.8M | 800k | 4.75 | |
| Aimmune Therapeutics | 1.0 | $3.7M | 165k | 22.35 | |
| Fortress Biotech | 1.0 | $3.6M | 2.0M | 1.78 | |
| Acorda Therapeutics | 1.0 | $3.5M | 265k | 13.29 | |
| Fennec Pharmaceuticals (FENC) | 0.8 | $3.1M | 630k | 4.85 | |
| Shockwave Med (SWAV) | 0.8 | $3.1M | 92k | 33.47 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.7 | $2.7M | 1.0M | 2.65 | |
| Liquidia Technologies (LQDA) | 0.7 | $2.6M | 225k | 11.38 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $2.2M | 115k | 19.50 | |
| Chimerix (CMRX) | 0.6 | $2.0M | 960k | 2.10 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.5 | $1.7M | 73k | 22.75 | |
| Establishment Labs Holdings Ord (ESTA) | 0.3 | $1.2M | 50k | 24.04 | |
| Zymeworks | 0.2 | $890k | 55k | 16.18 | |
| Synthorx | 0.2 | $815k | 40k | 20.38 | |
| Foamix Pharmaceuticals | 0.2 | $675k | 180k | 3.75 | |
| Kura Oncology (KURA) | 0.1 | $418k | 25k | 16.59 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $386k | 60k | 6.43 | |
| Biolinerx Ltd-spons | 0.0 | $108k | 250k | 0.43 |
